Vanda Pharmaceuticals, Inc. (VNDA)

7.265 -0.06 (-0.75%) USD  |  NASDAQ  |  Apr 15, 16:00
7.265 0.00 (0.00%) After-Hours: 16:49
More

Vanda Pharmaceuticals Research and Development Expense (Annual) : 109.27M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 13.34B
Gilead Sciences, Inc. 5.688B
Gossamer Bio, Inc. 174.07M
BridgeBio Pharma, Inc. 451.95M
Arcellx, Inc. 157.61M